-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Observations on patents and other IP from a dual-licensed practitioner
In October I wrote about the paragraph IV challenge to Eli Lilly’s anti-lung cancer drug Alimta®, royalties from which had paid in full for a new $280 million chemistry building…
A few weeks ago I posted about the Commissioner of Patents getting very publicly raked over the coals by a legislator for having unilaterally decided a few years earlier to…
Yesterday the latest copy of my college alumni magazine arrived. The magazine included an article on the campus’ new chemistry building, built at a cost of about 280 million dollars,…
As discussed in earlier posts, back in early 2001 The Medicines Company (TMC) missed by one day the deadline to request a patent term extension (PTE) for US 5,196,404, which…
I’m Dan Feigelson. I’ve been practicing patent law for over 30 years. I’m also opinionated, as you may discover in reading my writings here.
America-Israel Patent Law Blog 